| Trupti S Mehta, MD | |
|
2500 Merced St, San Leandro, CA 94577-4201 | |
| (510) 454-1000 | |
| Not Available |
| Full Name | Trupti S Mehta |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 2500 Merced St, San Leandro, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609954460 | NPI | - | NPPES |
| 00A520770 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A52077 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Veracyte, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by Veracyte, Inc.
"There has been so much news related to cholera and cholera research since the start of 2013 I can only hope it means this year will be a banner year for prevention efforts," Helen Matzger, a program officer in new vaccine delivery at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the January 14th submission of its single-level Mobi-C cervical artificial disc PMA to the FDA.
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients-such as in the ability to recall and concentrate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trupti S Mehta, MD 2500 Merced St, San Leandro, CA 94577-4201 Ph: (510) 454-1000 | Trupti S Mehta, MD 2500 Merced St, San Leandro, CA 94577-4201 Ph: (510) 454-1000 |
News Archive
Veracyte, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by Veracyte, Inc.
"There has been so much news related to cholera and cholera research since the start of 2013 I can only hope it means this year will be a banner year for prevention efforts," Helen Matzger, a program officer in new vaccine delivery at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the January 14th submission of its single-level Mobi-C cervical artificial disc PMA to the FDA.
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients-such as in the ability to recall and concentrate.
› Verified 8 days ago
Richard Allen Park, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 2500 Merced Street, San Leandro, CA 94577 Phone: 510-454-1000 | |
Sneha Alpesh Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Abida Sultana Azim, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Jabeen Abdulla Parkar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Jonathan Tsai, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-514-2872 | |
Priya Shastry, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-332-1499 | |
Amitesh Mishra, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 |